Role of T helper lymphokines in the immune-inflammatory pathophysiology of schizophrenia: Systematic review and meta-Analysis

Nordic Journal of Psychiatry

Volumn 69, Issue 5, 2015, Pages 364-372

  Guo, Jing ^a   Liu, Chaojun ^a   Wang, Yaxi ^a   Feng, Baie ^a   Zhang, Xueyan ^a  

^a 261th Hospital of the People's Liberation Army   (China)

Author keywords

Immune activation; Interleukin; Schizophrenia; T helper cells; Th1:Th2 ratio

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; LYMPHOKINE; CYTOKINE;

ARTICLE; CONFIDENCE INTERVAL; DATA BASE; HELPER CELL; HUMAN; IMMUNE SYSTEM; META ANALYSIS; PATHOPHYSIOLOGY; SCHIZOPHRENIA; SYSTEMATIC REVIEW; TH1 CELL; TH1 TH2 BALANCE; TH2 CELL; BLOOD; IMMUNOLOGY; METABOLISM;

CYTOKINES; HUMANS; LYMPHOKINES; SCHIZOPHRENIA; TH1 CELLS; TH2 CELLS;

EID: 84929889656     PISSN: 08039488     EISSN: 15024725     Source Type: Journal    
DOI: 10.3109/08039488.2014.986761     Document Type: Article

References (75)

1. Steinman L. Lessons learned at the intersection of immunology and neuroscience. J Clin Invest. 2012 ; 122 : 1146-1148
2. Gruol DL, Nelson TE. Physiological and pathological roles of interleukin-6 in the central nervous system. Mol Neurobiol. 1997 ; 15 : 307-339
3. Sommer IE, Van Westrhenen R, Begemann MJ, De Witte LD, Leucht S, Kahn RS. Efficacy of anti-infl ammatory agents to improve symptoms in patients with schizophrenia: An update. Schizophr Bull. 2014 ; 40 : 181-191
4. De Jong S, Van Eijk KR, Zeegers DW, Strengman E, Janson E, Veldink JH, et al ; PGC Schizophrenia (GWAS) Consortium. Expression QTL analysis of top loci from GWAS meta-Analysis highlights additional schizophrenia candidate genes. Eur J Hum Genet. 2012 ; 20 : 1004-1008
5. KeshaVan MS. Development, disease and Degeneration in schizophrenia: A unitary pathophysiological moDel. J Psychiatry Res. 1999 ; 33 : 513-521
6. Maynard TM, Sikich L, Lieberman JA, LaMantia AS. Neural Development, cell-cell signaling, and the two-hit hypothesis of schizophrenia. Schizophr Bull. 2001 ; 27 : 457-476
7. Meyer U. Developmental neuroinfl ammation and schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2013 ; 42 : 20-34
8. Boyajyan A, Khoyetsyan A, Tsakanova G, Sim RB. Cryoglobulins as indicators of upregulated immune response in schizophrenia. Clin Biochem. 2008 ; 41 : 355-360
9. Maes M, Bosmans E, Kenis G, De Jong R, Smith RS, Meltzer HY. In vivo immunomodulatory effects of clozapine in schizophrenia. Schizophr Res. 1997 ; 26 : 221-225
10. AnDerson G, Maes M. Schizophrenia: Linking prenatal infection to cytokines, the tryptophan catabolite (TRYCAT) pathway, NMDA receptor hypofunction, neuroDevelopment and neuroprogression. Prog Neuropsychopharmacol Biol Psychiatry. 2013 ; 42 : 5-19
11. Nottet HS, GenDelman HE. Unraveling the neuroimmune mechanisms for the HIV-1-Associated cognitive/motor complex. Immunol Today. 1995 ; 16 : 441-448
12. Kaul M, Zheng J, Okamoto S, GenDelman HE, Lipton SA. HIV-1 infection and AIDS: Consequences for the central nervous system. Cell Death Differ. 2005 ; 12 Suppl 1 : 878-892
13. Ibi D, Nagai T, Nabeshima T, Yamada K. PolyI:C-induced neuroDevelopmental animal moDel for schizophrenia]. Nihon Shinkei Seishin Yakurigaku Zasshi. 2011; 31: 201-207
14. Nawa H, Yamada K. Experimental schizophrenia moDels in roDents established with infl ammatory agents and cytokines. Methods Mol Biol. 2012 ; 829 : 445-451
15. Henneberg AE, Horter S, Ruffert S. Increased prevalence of antibrain antibodies in the sera from schizophrenic patients. Schizophr Res. 1994 ; 14 : 15-22
16. Schwarz MJ, RieDel M, Gruber R, Muller N, Ackenheil M. Autoantibodies against 60-kDa heat shock protein in schizophrenia. Eur Arch Psychiatry Clin Neurosci. 1998 ; 248 : 282-288
17. ArroDe-Bruses G, Bruses JL. Maternal immune activation by poly(I:C) induces expression of cytokines IL-1and IL-13, chemokine MCP-1 and colony stimulating factor VEGF in fetal mouse brain. J Neuroinfl ammation. 2012 ; 9 : 83
18. Ashdown H, Dumont Y, Ng M, Poole S, Boksa P, Luheshi GN. The role of cytokines in mediating effects of prenatal infection on the fetus: Implications for schizophrenia. Mol Psychiatry. 2006 ; 11 : 47-55
19. Brown AS, Derkits EJ. Prenatal infection and schizophrenia: A review of epiDemiologic and translational studies. Am J Psychiatry. 2010 ; 167 : 261-280
20. Khandaker GM, Zimbron J, Lewis G, Jones PB. Prenatal maternal infection, neuroDevelopment and adult schizophrenia: A systematic review of population based studies. Psychol Med. 2012 ; 16 : 1-19
21. Smith SEP, Li J, Garbett K, Mirnics K, Patterson PH. Maternal immune activation alters fetal brain Development through interleukin-6. J Neurosci. 2007 ; 27 : 10695-10702
22. Zuckerman L, Weiner I. Maternal immune activation leads to behavioral and pharmacological changes in the adult offspring. J Psychiatr Res. 2005 ; 39 : 311-323
23. Stevens B, Allen NJ, Vazquez LE, Howell GR, Christopherson KS, Nouri N, et al. The classical complement cascaDe mediates CNS synapse elimination. Cell. 2007 ; 131 : 1164-1178
24. Boulanger LM. Immune proteins in brain Development and synaptic plasticity. Neuron. 2009 ; 64 : 93-109
25. Samaroo D, Dickerson F, Kasarda DD, Green PH, Briani C, Yolken RH, et al. Novel immune response to gluten in individuals with schizophrenia. Schizophr Res. 2010 ; 118 : 248-255
26. Mayilyan KR, Weinberger DR, Sim RB. The complement system in schizophrenia. Drug News Perspect. 2008 ; 21 : 200-210
27. Arakelyan A, Zakharyan R, Khoyetsyan A, Poghosyan D, Aroutiounian R, Mrazek F, et al. Functional characterization of the complement receptor type 1 and its circulating ligands in patients with schizophrenia. BMC Clin Pathol. 2011 ; 11 : 10
28. Severance EGL, Gressitt KL, Halling M, Stallings CR, Origoni AE, Vaughan C, et al. Complement C1q formation of immune complexes with milk caseins and wheat glutens in schizophrenia. Neurobiol Dis. 2012 ; 48 : 447-453
29. Shcherbakova I, Neshkova E, Dotsenko V, Platonova T, Shcherbakova E, Yarovaya G. The possible role of plasma kallikreinkinin system and leukocyte elastase in pathogenesis of schizophrenia, Immunopharmacol. 1999 ; 43 : 273-279
30. Hakobyan S, Boyajyan A, Sim RB. Classical pathway complement activity in schizophrenia. Neurosci Lett. 2005 ; 374 : 35-37
31. Powell C, Thompson L, Murtaugh RJ. Type III hypersensitivity reaction with immune complex Deposition in 2 critically ill dogs administered human serum albumin. J Vet Emerg Crit Care (San Antonio). 2013 ; 23 : 598-604
32. Herken H, Uz E, Ozyurt H, Sogut S, Virit O, Akyol O. EviDence that the activities of erythrocyte free radical scavenging enzymes and the products of lipid peroxidation are increased in different forms of schizophrenia. Mol Psychiatry. 2001 ; 6 : 66-73
33. Zoroglu SS, Herken H, Yurekli M, Uz E, Tutkun H, SavapHA, et al. The possible pathophysiological role of plasma nitric oxiDe and adrenomedullin in schizophrenia. J Psychiatr Res. 2002 ; 36 : 309-315
34. Suzuki E, Nakaki T, Nakamura M, Miyaoka H. Plasma nitrate levels in Defi cit versus non-Defi cit forms of schizophrenia. J. Psychiatry Neurosci. 2003 ; 28 : 288-292
35. Akyol O, Zoroolu SS, Armutcu F, Sahin S, Gurel A. Nitric oxiDe as a physiopathological factor in neuropsychiatric disorDers. In Vivo. 2004 ; 18 : 377-390
36. Yao JK, Leonard S, Reddy RD. Increased nitric oxiDe radicals in postmortem brain from patients with schizophrenia. Schizophr Bull. 2004 ; 30 : 923-934
37. Li HC, Chen QZ, Ma Y, Zhou JF. Imbalanced free radicals and antioxidant Defense systems in schizophrenia: A comparative study. J Zhejiang Univ Sci B. 2006 ; 7 : 981-986
38. Zhang XY, Tan YL, Zhou DF, Cao LY, Wu GY, Haile CN, et al. Disrupted antioxidant enzyme activity and elevated lipid peroxidation products in schizophrenic patients with tardive dyskinesia. J Clin Psychiatry. 2007 ; 68 : 754-760
39. Fendri C, Mechri A, Khiari G, Othman A, Kerkeni A, Gaha L. Oxidative stress involvement in schizophrenia pathophysiology: A review. Encephale. 2006 ; 32 : 244-252
40. Karlsson H. Viruses and schizophrenia, connection or coinciDence? Neuroreport. 2003 ; 14 : 535-542
41. Altamura AC, Pozzoli S, Fiorentini A, Dell osso B. NeuroDevelopment and infl ammatory patterns in schizophrenia in relation to pathophysiology. Prog Neuropsychopharmacol Biol Psychiatry. 2013 ; 42 : 63-70
42. Prasad KM, Watson AM, Dickerson FB, Yolken RH, Nimgaonkar VL. Exposure to herpes simplex virus type 1 and cognitive impairments in individuals with schizophrenia. Schizophr Bull. 2012 ; 38 : 1137-1148
43. Carter CJ. Schizophrenia susceptibility genes directly implicated in the life cycles of pathogens: Cytomegalovirus, infl uenza, herpes simplex, rubella, and Toxoplasma gondii. Schizophr Bull. 2009 ; 35 : 1163-1182
44. Moreno JL, Kurita M, Holloway T, Lpez J, Cadagan R, Martinez-Sobrido L, et al. Maternal infl uenza viral infection causes schizophrenia-like alterations of 5-HT 2 A and mGlu 2 receptors in the adult offspring. J Neurosci. 2011 ; 31 : 1863-1872
45. Muller N, RieDel M, Ackenheil M, Schwarz MJ. The role of immune function in schizophrenia: An overview. Eur Arch Psychiatry Clin Neurosci. 1999 ; 249 : 62-68
46. Arolt V, Weitzsch C, Wilke I, Nolte A, Pinnow M, Rothermundt M, et al. Production of interferon-gamma in families with multiple occurrence of schizophrenia. Psychiatry Res. 1997 ; 66 : 145-152
47. Arolt V, Rothermundt M, Wandinger KP, Kirchner H. Decreased in vitro production of interferon-gamma and interleukin-2 in whole blood of patients with schizophrenia during treatment. Mol Psychiatry. 2000 ; 5 : 150-158
48. Avgustin B, Wraber B, Tavcar R. Increased Th1 and Th2 immune reactivity with relative Th2 dominance in patients with acute exacerbation of schizophrenia. Croat Med J. 2005 ; 46 : 268-274
49. Becker D, Kritschmann E, Floru S, Shlomo-David Y, Gotlieb-Stematsky T. Serum interferon in fi rst psychotic attack. Br J Psychiatry. 1990 ; 157 : 136-138
50. Bessler H, Levental Z, Karp L, Modai I, DjalDetti M, Weizman A. Cytokine production in drug-free and neuroleptic-treated schizophrenic patients. Biol Psychiatry. 1995 ; 38 : 297-302
51. Chiang SSW, RieDel M, Muller N, Ackenheil M, Gruber R, Schwarz M. Th2-shift in schizophrenia: Primary fi ndings from whole blood in vitro stimulation. http://www.priory.com/psych/th2.htm
52. Chiang SS, RieDel M, Schwarz M, Mueller N. Is T-helper type 2 shift schizophrenia-specifi c Primary results from a comparison of related psychiatric disorDers and healthy controls. Psychiatry Clin Neurosci. 2013 ; 67 : 228-236
53. Erbagci AB, Herken H, Koyluoglu O, Yilmaz N, Tarak C ioglu M. Serum IL-1beta, sIL-2R, IL-6, IL-8 and TNF-Alpha in schizophrenic patients, relation with symptomatology and responsiveness to risperidone treatment. Mediators Infl amm. 2001 ; 10 : 109-115
54. Gattaz WF, Dalgalarrondo P, SchrODer HC. Abnormalities in serum concentrations of interleukin-2, interferon-Alpha and interferon-gamma in schizophrenia not Detected. Schizophr Res. 1992 ; 6 : 237-241
55. Hornberg M, Arolt V, Wilke I, Kruse A, Kirchner H. Production of interferons and lymphokines in leukocyte cultures of patients with schizophrenia. Schizophr Res. 1995 ; 15 : 237-242
56. Igue R, Potvin S, Bah R, Stip E, Bouchard RH, Lipp O, et al. Soluble interleukin-2 receptor levels correlated with positive symptoms during quetiapine treatment in schizophrenia-spectrum disorDers. Prog Neuropsychopharmacol Biol Psychiatry. 2011 ; 35 : 1695-1698
57. Kamiska T1, Wysocka A, Marmurowska-Michalowska H, Dubas-Slemp H, KanDefer-Szersze M. Investigation of serum cytokine levels and cytokine production in whole blood cultures of paranoid schizophrenic patients. Arch Immunol Ther Exp (Warsz). 2001 ; 49 : 439-445
58. Kim YK, Lee MS, Suh KY. Decreased interleukin-2 production in Korean schizophrenic patients. Biol Psychiatry. 1998 ; 43 : 701-704
59. Kim YK, Myint AM, Lee BH, Han CS, Lee HJ, Kim DJ, et al. Th1, Th2 and Th3 cytokine alteration in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2004 ; 28 : 1129-1134
60. Krause D, Weidinger E, Dippel C, RieDel M, Schwarz MJ, Mller N, et al. Impact of different antipsychotics on cytokines and tryptophan metabolites in stimulated cultures from patients with schizophrenia. Psychiatr Danub. 2013 ; 25 : 389-397
61. Lin CC, Chang CM, Chang PY, Huang TL. Increased interleukin-6 level in Taiwanese schizophrenic patients. Chang Gung Med J. 2011 ; 34 : 375-381
62. Na KS, Kim YK. Monocytic, Th1 and th2 cytokine alterations in the pathophysiology of schizophrenia. Neuropsychobiol. 2007 ; 56 : 55-63
63. O Brien SM, Scully P, Dinan TG. Increased tumor necrosis factor-Alpha concentrations with interleukin-4 concentrations in exacerbations of schizophrenia. Psychiatry Res. 2008 ; 160 : 256-262
64. Rothermundt M, Arolt V, Weitzsch C, Eckhoff D, Kirchner H. Production of cytokines in acute schizophrenic psychosis. Biol Psychiatry. 1996 ; 40 : 1294-1297
65. Singh B, Bera NK, Nayak CR, Chaudhuri TK. Decreased serum levels of interleukin-2 and interleukin-6 in Indian Bengalee schizophrenic patients. Cytokine. 2009 ; 47 : 1-5
66. Wilke I, Arolt V, Rothermundt M, Weitzsch C, Hornberg M, Kirchner H. Investigations of cytokine production in whole blood cultures of paranoid and residual schizophrenic patients. Eur Arch Psychiatry Clin Neurosci. 1996 ; 246 : 279-284
67. Miller BJ, Buckley P, Seabolt W, Mellor A, Kirkpatrick B. Meta-Analysis of cytokine alterations in schizophrenia: Clinical status and antipsychotic effects. Biol Psychiatry. 2011 ; 70 : 663-671
68. Potvin S, Stip E, Sepehry AA, Gendron A, Bah R, Kouassi E. Infl ammatory cytokine alterations in schizophrenia: A systematic quantitative review. Biol Psychiatry. 2008 ; 63 : 801-808
69. Romagnani S. Th1/Th2 cells. Infl amm Bowel Dis. 1999 ; 5 : 285-294
70. Berger A. Science commentary: Th1 and Th2 responses: What are they? BMJ. 2000 ; 321 : 424
71. Said WM, Saleh R, Jumaian N. Prevalence of hepatitis B virus among chronic schizophrenia patients. East Mediterr Health J. 2001 ; 7 : 526-530
72. Hung CC, Loh el-W, Hu TM, Chiu HJ, Hsieh HC, Chan CH, et al. Prevalence of hepatitis B and hepatitis C in patients with chronic schizophrenia living in institutions. J Chin Med Assoc. 2012 ; 75 : 275-280
73. Xue Y, Sun X, Li Y, Liu X, Dong C. Increased risk of hepatitis E virus infection in schizophrenia. Arch Virol. 2013 ; 158 : 359-365
74. Hornig M, Briese T, Licinio J, Khabbaz RF, Altshuler LL, Potkin SG, et al. Absence of eviDence for bornavirus infection in schizophrenia, bipolar disorDer and major Depressive disorDer. Mol Psychiatry. 2012 ; 17 : 486-493
75. Oldstone MB. The game s afoot: Seeking viruses that cause chronic and Degenerative neurologic and psychiatric disorDer. Mol Psychiatry. 2012 ; 17 : 472-473